CoChat

IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo

Open access
Venkatanarayan, Avinashnarayan, Raulji, Payal, Norton, William, Chakravarti, Deepavali, Coarfa, Cristian, Su, Xiaohua, Sandur, Santosh K., Ramirez, Marc S., Lee, Jaehuk, Kingsley, Charles V., Sananikone, Eliot F., Rajapakshe, Kimal, Naff, Katherine, Parker-Thornburg, Jan, Bankson, James A., Tsai, Kenneth Y., Gunaratne, Preethi H., Flores, Elsa R. · 2015 · Nature
Cited by 130

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

TP53 is commonly altered in human cancer, and Tp53 reactivation suppresses tumours in vivo in mice (TP53 and Tp53 are also known as p53). This strategy has proven difficult to implement therapeutically, and here we examine an alternative strategy by manipulating the p53 family members, Tp63 and Tp73 (also known as p63 and p73, respectively). The acidic transactivation-domain-bearing (TA) isoforms of p63 and p73 structurally and functionally resemble p53, whereas the ΔN isoforms (lacking the acidic transactivation domain) of p63 and p73 are frequently overexpressed in cancer and act primarily in a dominant-negative fashion against p53, TAp63 and TAp73 to inhibit their tumour-suppressive functions. The p53 family interacts extensively in cellular processes that promote tumour suppression, such as apoptosis and autophagy, thus a clear understanding of this interplay in cancer is needed to treat tumours with alterations in the p53 pathway. Here we show that deletion of the ΔN isoforms of p63 or p73 leads to metabolic reprogramming and regression of p53-deficient tumours through upregulation of IAPP, the gene that encodes amylin, a 37-amino-acid peptide co-secreted with insulin by the β cells of the pancreas. We found that IAPP is causally involved in this tumour regression and that amylin functions through the calcitonin receptor (CalcR) and receptor activity modifying protein 3 (RAMP3) to inhibit glycolysis and induce reactive oxygen species and apoptosis. Pramlintide, a synthetic analogue of amylin that is currently used to treat type 1 and type 2 diabetes, caused rapid tumour regression in p53-deficient thymic lymphomas, representing a novel strategy to target p53-deficient cancers.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature13910

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 130

Metadata

Authors
Venkatanarayan, A., Raulji, P., Norton, W., Chakravarti, D., Coarfa, C., Su, X., Sandur, S. K., Ramirez, M. S., Lee, J., Kingsley, C. V., Sananikone, E. F., Rajapakshe, K., Naff, K., Parker-Thornburg, J., Bankson, J. A., Tsai, K. Y., Gunaratne, P. H., & Flores, E. R.
Venue
Nature
Published
2014-11-17
Volume
517
Issue
7536
Pages
626-630
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2064345296
Cited by
130
References
19
FWCI
6.61
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. https://app.cochat.ai/papers/10.1038/nature13910
The paper
Venkatanarayan, A., Raulji, P., Norton, W., Chakravarti, D., Coarfa, C., Su, X., Sandur, S. K., Ramirez, M. S., Lee, J., Kingsley, C. V., Sananikone, E. F., Rajapakshe, K., Naff, K., Parker-Thornburg, J., Bankson, J. A., Tsai, K. Y., Gunaratne, P. H., & Flores, E. R. (2015). IAPP-driven metabolic reprogramming induces regression of p53-deficient tumours in vivo. Nature. https://doi.org/10.1038/nature13910

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.